Position in DYN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$83,141,513
+$19,611,927 QoQ
Shares Held
3,743,427
+6.8% QoQ
Ownership
2.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 245 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. DYN ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,141,513 | 3,743,427 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $63,529,586 | 3,504,114 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $63,832,670 | 3,263,429 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $36,275,202 | 2,867,605 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $21,454,938 | 2,253,670 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $20,454,582 | 1,955,505 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $44,465,471 | 1,887,329 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $66,790,114 | 1,859,413 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $62,627,503 | 1,774,653 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $37,122,877 | 1,307,604 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $12,406,745 | 932,838 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,685,081 | 857,710 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,315,842 | 739,186 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,549,373 | 568,522 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,334,572 | 546,555 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,776,935 | 533,617 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,428,940 | 499,118 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,712,051 | 488,802 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,742,227 | 482,946 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,748,109 | 415,524 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,724,172 | 414,647 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,517,614 | 290,896 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,956,105 | 236,005 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||